-
Mashup Score: 8Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19 | mBio - 1 month(s) ago
As SARS-CoV-2 evolves, new variants of concern (VOCs) have emerged that evade available anti-spike monoclonal antibodies, particularly among immunosuppressed patients. However, high-titer COVID-19 convalescent plasma continues to be effective against VOCs …
Source: journals.asm.orgCategories: General Medicine News, Hem/OncsTweet
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and #COVID19 [Apr 14, 2024] @JuanGRipoll1 et al. @mbiojournal https://t.co/LVKzhGpfIr #COVID19CP #COVID19Vaccine https://t.co/qJvLN6y2xA